Guanghui Li1, Lijun Kong1, Li Zhang1, Ling Fan1, Yixin Su2, James C Rose2, Weiyuan Zhang3. 1. Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China. 2. Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, NC, USA. 3. Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China zhangwy9921@163.com.
Abstract
OBJECTIVE: To determine associations between lipid profiles in early pregnancy stratified by body mass index (BMI) and risk of developing gestational diabetes mellitus (GDM). STUDY DESIGN: A total of 2488 healthy pregnant women were enrolled prospectively. Fasting plasma lipid profiles were measured at mean 11 weeks of gestation including triglycerides (TGs), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and cholesterol (CHO). We assessed early pregnancy maternal lipid concentrations in different tertiles in association with the risk of GDM stratified for BMI. Multivariable logistic regression analyses were used to estimate the relative risk of GDM by calculating odds ratios and 95% confidence intervals (CIs). RESULTS: In univariate analyses, pregnant women with GDM had significantly increased serum TG, CHO, LDL concentrations, LDL/HDL ratio, and decreased LDL concentrations, compared to control groups, each P < .01, respectively. After adjustment for confounders, there was a 1.8-fold increase in risk for GDM in the lean group (95% CI: 1.2-2.7) and 2.7-fold increase in the obese group (95% CI: 1.1-6.6), respectively, if TG ≥ 1.58 mmol/L. About a 50% decrease in the risk of GDM was observed in lean women with HDL ≥ 2.22 mmol/L (95% CI: 0.3-0.9). No significant correlations of other lipid profiles with the risk of developing GDM were observed. CONCLUSION: Early pregnancy dyslipidemia is associated with the risk of developing GDM. Lean or obese women with higher TG concentrations are at an increased risk for developing GDM while lean women with high HDL are protected.
OBJECTIVE: To determine associations between lipid profiles in early pregnancy stratified by body mass index (BMI) and risk of developing gestational diabetes mellitus (GDM). STUDY DESIGN: A total of 2488 healthy pregnant women were enrolled prospectively. Fasting plasma lipid profiles were measured at mean 11 weeks of gestation including triglycerides (TGs), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and cholesterol (CHO). We assessed early pregnancy maternal lipid concentrations in different tertiles in association with the risk of GDM stratified for BMI. Multivariable logistic regression analyses were used to estimate the relative risk of GDM by calculating odds ratios and 95% confidence intervals (CIs). RESULTS: In univariate analyses, pregnant women with GDM had significantly increased serum TG, CHO, LDL concentrations, LDL/HDL ratio, and decreased LDL concentrations, compared to control groups, each P < .01, respectively. After adjustment for confounders, there was a 1.8-fold increase in risk for GDM in the lean group (95% CI: 1.2-2.7) and 2.7-fold increase in the obese group (95% CI: 1.1-6.6), respectively, if TG ≥ 1.58 mmol/L. About a 50% decrease in the risk of GDM was observed in lean women with HDL ≥ 2.22 mmol/L (95% CI: 0.3-0.9). No significant correlations of other lipid profiles with the risk of developing GDM were observed. CONCLUSION: Early pregnancy dyslipidemia is associated with the risk of developing GDM. Lean or obesewomen with higher TG concentrations are at an increased risk for developing GDM while lean women with high HDL are protected.
Authors: M Rizzo; K Berneis; A E Altinova; F B Toruner; M Akturk; G Ayvaz; G B Rini; G A Spinas; M Arslan Journal: Diabet Med Date: 2008-12 Impact factor: 4.359
Authors: Peng Ju Liu; Yanping Liu; Liangkun Ma; Ai Min Yao; Xiao Yan Chen; Yi Xuan Hou; Li Ping Wu; Liang Yu Xia Journal: Diabetes Metab Syndr Obes Date: 2020-06-16 Impact factor: 3.168
Authors: Erin S LeBlanc; Ning X Smith; Kimberly K Vesco; Teresa A Hillier; Victor J Stevens Journal: J Clin Endocrinol Metab Date: 2021-11-19 Impact factor: 6.134